Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group
Report from the 1995 Core Indicators for Peritoneal Dialysis Study Group
复制标题
DOI：
10.1016/s0272-6386(97)90049-4
复制
发表时间：
1997-08-01
影响因子：
13.2
通讯作者：
Helgerson, SD
中科院分区：
文献类型：
--
作者：
Rocco, MV;Flanigan, MJ;Helgerson, SD
1995年腹膜透析核心指标研究由卫生保健融资管理局进行，以确定慢性腹膜透析患者的标准实践和结局，数据来自1，202例未接受血液透析但在1994年11月1日期间至少部分6个月期间接受慢性非卧床腹膜透析（CAPD）的患者;和1995年4月30日报道，通过溴甲酚紫方法，该队列的平均血清白蛋白水平为3.5 g/dL，仅34%的患者提交了足以计算每周Kt/V-尿素或每周肌酐清除率的数据，在这些患者中，使用0.58 x体重的V固定值，每周Kt/V-尿素中位数为1.7，使用沃森公式计算V时为2.0;平均每周肌酐清除率为60.7 L/wk/1.73 m2，该队列的平均红细胞压积为32%，平均每周重组人促红细胞生成素（rHmEPO）剂量为115 u/kg。在50%的黑人患者和31%的白色患者中发现红细胞压积值小于或等于30%。腹膜透析患者的平均血压为139/80 mm Hg，29%的患者收缩压超过150 mm Hg，18%的患者舒张压大于90 mm Hg。总之，腹膜透析患者的血清白蛋白水平显著低于血液透析患者，约三分之一的腹膜透析患者在6个月观察期内未获得充分性指标。少数患者患有治疗不充分的慢性肾病贫血或高血压。有机会大大改善向慢性腹膜透析患者提供的医疗护理。(C)1997年由国家肾脏基金会，公司。
The 1995 Peritoneal Dialysis Core Indicators Study was conducted by the Health Care Financing Administration to ascertain standard practices and Outcomes in chronic peritoneal dialysis patients, Data from 1,202 patients who did not receive hemodialysis but who were on chronic ambulatory peritoneal dialysis (CAPD) for at least part of the 6-month period between November 1, 1994; and April 30, 1995, are reported, The mean serum albumin level for this cohort was 3.5 g/dL by the bromcresol purple method, Data sufficient to calculate a weekly Kt/V-urea or weekly creatinine clearance were available for only 34% of patient submissions, in these patients, the median weekly Kt/V-urea was 1.7 using a fixed value for V of 0.58 x body weight and was 2.0 using the Watson equation to calculate V; the median weekly creatinine clearance was 60.7 L/wk/1.73 m(2), The mean hematocrit for this cohort was 32% and the average weekly recombinant human erythropoietin (rHmEPO) dose was 115 u/kg. Hematocrit values less than or equal to 30% were found in 50% of black patients and 31% of white patients. The average blood pressure among peritoneal dialysis patients was 139/80 mm Hg, with 29% of patients having a systolic blood pressure exceeding 150 mm Hg and 18% a diastolic blood pressure greater than 90 mm Hg. In summary, serum albumin levels were significantly lower in peritoneal dialysis patients than in hemodialysis patients, Approximately one third of peritoneal dialysis patients did not have an adequacy measure obtained during the 6-month observation period. A significant minority of patients had either inadequately treated anemia of chronic renal disease or hypertension. There is an opportunity to substantially improve the medical care provided to chronic peritoneal dialysis patients. (C) 1997 by the National Kidney Foundation, Inc.